FARE - Food Allergy Research & Education Logo

Media Room

In The News

Spotting a teal pumpkin on Halloween could save a child’s life.

Today.com

The nasal spray Neffy is the first non-injectable epinephrine to treat the life-threatening allergic response

People

Food Protein-Induced Enterocolitis Syndrome, known as FPIES, affects an estimated 90,000 people in the U.S. – about 5 in 1,000 children and 2 in 1,000 adults – and most parents have never heard of it.

Greenville News

Neffy is the first epinephrine product that’s needle-free.

Motherly

It marks the first needle-free form of epinephrine for serious allergic reactions to food, medications and insect stings.

Washington Post

Food Protein-Induced Enterocolitis Syndrome, known as FPIES, affects an estimated 90,000 people in the U.S. – about 5 in 1,000 children and 2 in 1,000 adults – and most parents have never heard of it.

Citizen Times

Media Contact: 

media@foodallergy.org.
 


About FARE

FARE (Food Allergy Research & Education) is the leading nonprofit organization that empowers the food allergy patient across the journey of managing their disease. FARE delivers innovation by focusing on three strategic pillars—advocacy, research, and education—united by the through line of health equity. FARE’s initiatives accelerate the future of food allergy through effective policies and legislation, novel strategies toward prevention, diagnosis, and treatment, and building awareness and community. For more information, visit FoodAllergy.org.

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies.